NCT05523271

Brief Summary

This study is to assess the sensitivity and added benefits of CADEYE compared to standard care (white-light) in detecting colon polyps in patients undergoing colonoscopy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 31, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

January 16, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2023

Completed
Last Updated

January 19, 2023

Status Verified

January 1, 2023

Enrollment Period

8 months

First QC Date

August 29, 2022

Last Update Submit

January 16, 2023

Conditions

Keywords

Colorectal Cancer screening

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    Adenoma detection rate is the primary end point which is the percentage of patients with at least 1 histologically proven adenoma or carcinoma.

    1 year

Secondary Outcomes (4)

  • Adenomas detected per colonoscopy

    1 year

  • Proximal Adenoma detection rate

    1 year

  • Withdrawal time

    1 year

  • Non-neoplastic detection rate

    1 year

Study Arms (2)

Patients undergoing White Light Endoscopy (standard of care)

NO INTERVENTION

All subjects in Experimental Arm A will undergo SOC (white-light endoscopy).

Patients undergoing CAD EYE endoscopy

EXPERIMENTAL

All subjects in Experimental Arm B will undergo CADEYE endoscopy.

Diagnostic Test: CAD EYE (Computer Aided Diagnosis ----?

Interventions

CADEYE is a CAD-e system (FUJIFILM) that enables real-time video processing at the same rate as the standard procedure and and allows a real time computer aided detection of polyps with high accuracy.

Patients undergoing CAD EYE endoscopy

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old subjects
  • Subjects undergoing colonoscopy for the following: o Primary CRC screening
  • Post-polypectomy surveillance
  • Work up following FIT positivity
  • Symptoms/signs suspicions of CRC
  • Subjects must be willing to give written informed consent for the trial

You may not qualify if:

  • Unable to consent
  • Contraindicated to undergo endoscopy
  • Hospitalized patient
  • Patients with the following conditions:
  • History of colon resection
  • History of CRC
  • Antithrombotic therapy precluding colon resection o Inflammatory Bowel Disease (IBD)
  • Familial Adenomatous Polyposis (FAP)
  • Pregnant or lactating
  • Poor bowel preparation: BBPS 0 or 1 in a segment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Theodor Bilharz Research Institute

Giza, 12311, Egypt

RECRUITING

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

Diagnosis, Computer-Assisted

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Diagnosis

Central Study Contacts

Mostafa Ibrahim, M.D PhD

CONTACT

Farah Ebrahim, Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mostafa Ibrahim

Study Record Dates

First Submitted

August 29, 2022

First Posted

August 31, 2022

Study Start

January 16, 2023

Primary Completion

August 30, 2023

Study Completion

August 30, 2023

Last Updated

January 19, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations